Organogenesis Holdings Inc.
ORGO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $535 | $464 | $546 | $421 |
| - Cash | $64 | $73 | $110 | $136 |
| + Debt | $41 | $41 | $43 | $43 |
| Enterprise Value | $513 | $432 | $478 | $329 |
| Revenue | $151 | $101 | $87 | $127 |
| % Growth | 49.7% | 16.2% | -31.6% | – |
| Gross Profit | $115 | $73 | $63 | $96 |
| % Margin | 76% | 72.6% | 72.6% | 75.5% |
| EBITDA | $27 | -$6 | -$16 | $15 |
| % Margin | 18.1% | -6.2% | -18.3% | 11.6% |
| Net Income | $22 | -$9 | -$19 | $8 |
| % Margin | 14.3% | -9.3% | -21.7% | 6.1% |
| EPS Diluted | 0.11 | -0.096 | -0.17 | 0.058 |
| % Growth | 214.3% | 43.4% | -392.6% | – |
| Operating Cash Flow | $3 | -$33 | -$20 | $11 |
| Capital Expenditures | -$2 | -$4 | -$4 | -$3 |
| Free Cash Flow | $1 | -$37 | -$24 | $8 |